Enhanced biocompatibility and endothelialization of silk fibroin-derived peptide-based coating for cardiovascular tissue engineering applications
Biointerphases · 01.07.2026 · 21 (4)
DOI: 10.1116/6.0005463 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biointerphases, online erschienen am 06.08.2026. Verfasst von Juo Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Convergent Biosystems Engineering, College of Life Sciences, Sunchon National University, 255, Jungang-ro, Suncheon-si, Jeollanam-do 57…. Hauptthemen laut MEDLINE: Fibroins, Tissue Engineering, Peptides, Endothelial Cells. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Daejeon St. Mary's Hospital, Korean Society of Interventional Cardiology, Catholic Medical Center Research Foundation.
Abstract (Originalsprache)
Polycaprolactone (PCL) has emerged as a promising biomaterial for artificial heart applications due to its biodegradability and mechanical properties. However, its hydrophobic nature and limited biocompatibility pose challenges for cardiovascular applications, requiring optimal cell-material interactions. This study investigates the surface modification of silk fibroin-derived peptide/PCL coatings to enhance biocompatibility and cellular response for potential artificial heart applications. PCL substrates were blended with varying concentrations of silk fibroin-derived peptide (0.2%, 0.5%, and 1% w/v). Surface characterization was performed using water contact angle measurements, Fourier transform infrared spectroscopy (FTIR), and scanning electron microscopy. Biocompatibility was evaluated through cell viability assays and CD31 expression analysis. Silk fibroin-derived peptide incorporation significantly improved surface hydrophilicity, with contact angles decreasing from 78° (bare PCL) to 62° (1% silk fibroin-derived peptide). FTIR analysis confirmed successful incorporation of silk fibroin-derived peptides, showing characteristic PCL ester C=O absorption at ∼1720 cm−1 and concentration-dependent amide I contributions at ∼1630–1670 cm−1. Cell viability studies demonstrated enhanced cellular response with increasing silk fibroin-derived peptide concentration, particularly evident at day 7. CD31 expression analysis revealed improved endothelial marker expression, with the highest levels observed on 1% silk fibroin-derived peptide-incorporated substrates. The results demonstrate that silk fibroin blended to PCL significantly enhances biocompatibility through improved hydrophilicity and cellular interactions. Taken together, these preliminary results indicate that silk fibroin-derived peptide-incorporated PCL could represent a promising biomaterial platform for artificial heart applications, with the potential to improve endothelial compatibility and support endothelialization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Convergent Biosystems Engineering, College of Life Sciences, Sunchon National University, 255, Jungang-ro, Suncheon-si, Jeollanam-do 57922, Republic of Korea.
- Interdisciplinary Program in IT-Bio Convergence System, Sunchon National University, 255, Jungang-ro, Suncheon-si, Jeollanam-do 57922, Republic of Korea.
- Division of Industrial Insect and Sericulture, National Institute of Agricultural Sciences, Rural Development Administration, Wanju-gun, Jeollabuk-do 55365, Republic of Korea.
- Department of Agricultural Biology, Apiculture Division, National Institute of Agricultural Sciences, Rural Development Administration, Wanju-gun, Jeollabuk-do 55365, Republic of Korea.
- Clinical Research Institute, Daejeon St. Mary's hospital, College of Medicine, The Catholic University of Korea, 64, Daeheung-ro, Jung-gu, Daejeon 34943, Republic of Korea.
- Division of Cardiology, Daejeon St. Mary's hospital, College of Medicine, The Catholic University of Korea, 64, Daeheung-ro, Jung-gu, Daejeon 34943, Republic of Korea.
ORCID-Profile: Juo Lee, Jae Woon Lim, Hoon Seonwoo, Hae Yong Kweon, You-Young Jo, Jeong-Min Oh, Dae-Won Kim
Förderung
- Daejeon St. Mary's Hospital
- Korean Society of Interventional Cardiology
- Catholic Medical Center Research Foundation
- Information Technology Research Center
Zitieren
APA
Lee, J., Lim, J. W., Seonwoo, H., Kweon, H. Y., Jo, Y. Y., Oh, J. M., & Kim, D. W. (2026). Enhanced biocompatibility and endothelialization of silk fibroin-derived peptide-based coating for cardiovascular tissue engineering applications. Biointerphases, 21(4). https://doi.org/10.1116/6.0005463
Vancouver
Lee J, Lim JW, Seonwoo H, Kweon HY, Jo YY, Oh JM, et al. Enhanced biocompatibility and endothelialization of silk fibroin-derived peptide-based coating for cardiovascular tissue engineering applications. Biointerphases. 2026;21(4). doi:10.1116/6.0005463
BibTeX
@article{Lee2026,
author = {Lee, Juo and Lim, Jae Woon and Seonwoo, Hoon and Kweon, Hae Yong and Jo, You-Young and Oh, Jeong-Min and Kim, Dae-Won},
title = {Enhanced biocompatibility and endothelialization of silk fibroin-derived peptide-based coating for cardiovascular tissue engineering applications},
journal = {Biointerphases},
year = {2026},
volume = {21},
number = {4},
doi = {10.1116/6.0005463}
}
EUVIMED